Novel ATP-competitive MEK inhibitor E6201 is effective against vemurafenib-resistant melanoma harboring the MEK1-C121S mutation in a preclinical model (Q42241999)
Jump to navigation
Jump to search
scientific article published on 21 January 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Novel ATP-competitive MEK inhibitor E6201 is effective against vemurafenib-resistant melanoma harboring the MEK1-C121S mutation in a preclinical model |
scientific article published on 21 January 2014 |
Statements
1 reference
Novel ATP-competitive MEK inhibitor E6201 is effective against vemurafenib-resistant melanoma harboring the MEK1-C121S mutation in a preclinical model (English)
1 reference
Yusuke Narita
1 reference
Kiyoshi Okamoto
1 reference
Megumi Ikemori Kawada
1 reference
Kazuma Takase
1 reference
Yukinori Minoshima
1 reference
Kotaro Kodama
1 reference
Masao Iwata
1 reference
Norimasa Miyamoto
1 reference
Kohei Sawada
1 reference
21 January 2014
1 reference
1 reference
1 reference
Identifiers
1 reference